$15.63
2.2516.82%
Last update: Nov 9, 7:53 PM
Iambic Therapeutics Inc (IAM) Stock Price, Quote, News & History
IAMNASDAQ
Iambic Therapeutics shares surge as BofA and Jefferies initiate coverage with Buy ratings and bullish price targets.
You can purchase shares of Iambic Therapeutics (NASDAQ:IAM) through any online brokerage.
Other companies in Iambic Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Iambic Therapeutics has a consensus price target of $24.67.
The stock price for Iambic Therapeutics (NASDAQ: IAM) is $15.63 last updated November 9, 2026 at 7:53 PM EST.
There are no upcoming dividends for Iambic Therapeutics.
Iambic Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Iambic Therapeutics.
Iambic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.
